Video

Dr. Singh on the Potential Effects of Radiation Timing in Head and Neck Cancer

Anurag Singh, MD, discusses the potential effects of radiation timing in head and neck cancer.

Anurag Singh, MD, professor of oncology, director of radiation research, Department of Radiation Medicine, co-leader, Cell Stress and Biophysical Therapies Program, associate dean of graduate medical education, Research, Roswell Park Comprehensive Cancer Center, professor of medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, discusses the potential effects of radiation timing in head and neck cancer.

Interest has been generated regarding the potential effect of circadian rhythm on radiation therapy, Singh says. Prior data comparing outcomes and toxicities of patients treated with radiation therapy early in the morning vs late in the afternoon did not demonstrate significant differences.

However, a retrospective trial demonstrated that radiation treatment time was significantly associated with oral mucositis severity. The severity was lowest for patients treated between 8:30am and 9:30am, increased and peaked between 11:30am and 3:00pm, and decreased substantially after 3:00pm.

Although these data reflect a similar severity of oral mucositis between early morning and late afternoon treatment, they also suggest that additional research is needed to determine why patients treated with radiation therapy in the middle of the day experienced increased toxicity vs those treated in the early morning or late afternoon, Singh concludes.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Latest CME

View All
Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC
Video

Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC

Jun 6th 2025 - Jul 12th 2025

online-activity
Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation
Video

Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation

Jun 6th 2025 - Jul 12th 2025

online-activity
Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing
Video

Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing

Jun 5th 2025 - Jul 12th 2025

online-activity